《沪深两市》上证深成全日近高收成交破万亿 大金融股强势 贵州茅台扬6%
中国人民银行公开市场今日进行100亿元人民币(下同)7天期逆回购操作，今日有100亿元逆回购到期；中标利率持平於2.2%。人汇走强。上证深成今早高开後走势强劲，受大金融股助力下，各指数升幅扩大。A股午後愈升愈有，均以近高位收市，沪深两市成交突破万亿元。
上证高见3,584，全日升84点或2.4%，近高收报3,581点；深成升339点或2.3%，收报14,846点；沪深300指数升162点或3.2%，收报5,318点，为去年10月以来最大涨幅。创业板指数升87点或2.8%，收报3,227点，成交1,795亿元。沪深两市成交分别为4,722亿元及5,341亿元。
大金融股持续上升，券商、保险、银行等领涨沪深两市，厦门银行(601187.SH)、中信建投(601066.SH)、哈投股份(600864.SH)、湘财股份(600095.SH)涨停。平安银行(000001.SZ)、兴业银行(601166.SH)、招商银行(600036.SH)、宁波银行(002142.SZ)、华创阳安(600155.SH)、重庆银行(601963.SH)、青岛银行(002948.SZ)升4.5%-6.9%。中国人寿(601628.SH)、中国人保(601319.SH)分别升4.1%、2%。重磅中资金融股工行(601398.SH)、建行(601939.SH)分别升1.4%、2.2%。
白酒、食品股显着上扬，泸州老窖(000568.SZ)、贵州茅台(600519.SH)、五粮液(000858.SZ)扬7.3%、6%、5.9%。海天味业(603288.SH)升3.2%，绝味食品(603517.SH)分别升4.9%及3.6%。
半导体股午後走强，思瑞浦涨(688536.SH)、兆易创新(603986.SH)分别涨11.4%、8.9%。国机精工(002046.SZ)涨停，兆易创新涨近9%。
生物疫苗股上扬，未名医药(002581.SZ)涨停。智飞生物(300122.SZ)、康泰生物(300601.SZ)、沃森生物(300142.SZ)、康希诺(688185.SH)、复星医药(600196.SH)升2.3%-5.1%。方盛制药(603998.SH)拟转让佰骏医疗部份股权，引入战投德维特公司，股价涨停。
钢铁股永兴材料(002756.SZ)持续下跌，今日逆市再挫5.9%。受惠纸价大涨，连日上扬造纸股岳阳林纸(600963.SH)今再涨停。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
